Pharmacist Zeinab Ardeshir from PillSorted explores the complexities of menopausal weight changes and how GLP-1 injections might offer a pathway to better health and well-being
Suicide Risk with Bariatric Surgery Raises Concerns About GLP-1 Questions about a link between suicidality and GLP-1 agonists first came to public awareness in July 2023, when the Icelandic national health department described three patients taking the drugs, two of whom had suicidal thoughts and one who engaged in self-harm
Start your intake Why Weight Loss Slows Down on Semaglutide When you first begin semaglutide, your body responds to a powerful appetite-suppressing signal
Quick Answer: Current evidence from European and US regulatory reviews does not establish a causal link between Wegovy (semaglutide) and mental health disorders, though monitoring continues
In rare cases, prolonged erections (priapism) may require medical care
In 2025, the Diabetes Treatment application segment holds the largest share of the Semaglutide API market at approximately 47.3% of global revenue, reflecting semaglutide's established role as Ozempic and Rybelsus for type 2 diabetes management with HbA1c reductions of 1.5% to 1.9% supported by major clinical guidelines
